Bombay Hospital & Medical Research Center Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01591200
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Bombay Hospital and Medical Research Council | Bombay Hospital & Medical Research Center, Mumbai

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Alcoholic (Phase 2)

Pulmonary Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2